Alkem Laboratories Ltd. | Large-cap | Healthcare
₹4,906.50
1.35%
| Alkem Laboratories Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 129.6B
Gross Profit 82.0B 63.25%
Operating Income 21.5B 16.62%
Net Income 22.2B 17.09%
EPS (Diluted) ₹181.11

Balance Sheet Metrics

Total Assets 176.9B
Total Liabilities 52.6B
Shareholders Equity 124.3B
Debt to Equity 0.42

Cash Flow Metrics

Operating Cash Flow 18.4B
Free Cash Flow 12.4B

Revenue & Profitability Trend

Alkem Laboratories Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 129.6B 124.4B 114.4B 105.1B 87.3B
Cost of Goods Sold 47.6B 50.3B 49.8B 42.8B 35.9B
Gross Profit 82.0B 74.1B 64.6B 62.3B 51.4B
Operating Expenses 32.3B 30.1B 27.2B 22.0B 16.2B
Operating Income 21.5B 19.8B 13.3B 17.7B 16.7B
Pre-tax Income 25.3B 20.2B 13.0B 18.4B 18.4B
Income Tax 3.1B 2.1B 3.0B 1.6B 2.2B
Net Income 22.2B 18.1B 10.1B 16.8B 16.2B
EPS (Diluted) ₹181.11 ₹150.19 ₹82.31 ₹137.63 ₹132.57

Income Statement Trend

Alkem Laboratories Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 109.5B 104.1B 87.3B 84.4B 69.3B
Non-Current Assets 67.5B 51.6B 50.3B 56.3B 45.9B
Total Assets 176.9B 155.7B 137.6B 140.7B 115.2B
Liabilities
Current Liabilities 39.6B 39.9B 37.1B 48.1B 36.0B
Non-Current Liabilities 12.9B 8.7B 6.1B 4.2B 3.6B
Total Liabilities 52.6B 48.6B 43.2B 52.2B 39.6B
Equity
Total Shareholders Equity 124.3B 107.1B 94.4B 88.5B 75.6B

Balance Sheet Composition

Alkem Laboratories Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 25.3B 20.2B 13.0B 18.4B 18.4B
Operating Cash Flow 18.4B 14.5B 15.0B 8.2B 11.9B
Investing Activities
Capital Expenditures -6.3B -1.9B -2.3B -3.3B -1.8B
Investing Cash Flow -16.5B -12.5B -342.6M -15.3B -11.1B
Financing Activities
Dividends Paid -5.0B -5.4B -5.3B -4.2B -3.3B
Financing Cash Flow -11.8B -10.6B -16.4B 4.4B -2.0B
Free Cash Flow 12.4B 16.9B 14.5B 7.7B 10.7B

Cash Flow Trend

Alkem Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 26.38
Forward P/E 22.31
Price to Book 4.76
Price to Sales 4.40
PEG Ratio 22.31

Profitability Ratios

Profit Margin 16.70%
Operating Margin 8.87%
Return on Equity 19.14%
Return on Assets 8.10%

Financial Health

Current Ratio 2.76
Debt to Equity 11.11
Beta 0.42

Per Share Data

EPS (TTM) ₹180.92
Book Value per Share ₹1,002.92
Revenue per Share ₹1,084.29

Financial data is updated regularly. All figures are in the company's reporting currency.